分类: 新闻
SOM Biotech announces Phase 2b study results
SOM Biotech presents the Phase 2b study results with SOM3355 demonstrating a unique profile with robust improvements of chorea in Huntington’s Disease Patients and a safe profile with no somnolence, no akathisia and no impact 阅读更多...
0 条评论